Zafirlukast (AvPAK)
Welcome to the PulseAid listing for the Zafirlukast drug offered from AvPAK. This Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AvPAK |
NON-PROPRIETARY NAME: | Zafirlukast |
SUBSTANCE NAME: | ZAFIRLUKAST |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-09-15 |
END MARKETING DATE: | 0000-00-00 |
Zafirlukast HUMAN PRESCRIPTION DRUG Details:
Item Description | Zafirlukast from AvPAK |
LABELER NAME: | AvPAK |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2017-09-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50268-805_c063565a-bf48-4941-9db5-aff7b39412c7 |
PRODUCT NDC: | 50268-805 |
APPLICATION NUMBER: | ANDA090372 |
Other ZAFIRLUKAST Pharmaceutical Manufacturers / Labelers: